Dr. Agarwal's Health Care Financials
NSE: AGARWALEYE | BSE: 544350
₹488.00
As on 16-Sep-2026 09:34IST
Market cap
₹15,935 Cr
Revenue (TTM)
₹2,207 Cr
P/E Ratio
107.4
P/B Ratio
7.7
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,206.68
|
2,080.08
|
1,711.00
|
1,332.15
|
1,017.98
|
696.08
|
|||||
|
Total Income
|
2,244.14
|
2,130.39
|
1,768.32
|
1,381.50
|
1,036.47
|
717.82
|
|||||
|
Total Expenditure
|
1,594.56
|
1,508.80
|
1,259.53
|
970.03
|
748.10
|
514.40
|
|||||
|
EBITDA
|
612.12
|
571.28
|
451.47
|
362.12
|
269.88
|
181.68
|
|||||
|
Depreciation
|
291.60
|
276.24
|
230.74
|
170.37
|
128.30
|
97.66
|
|||||
|
EBIT
|
320.52
|
295.04
|
220.73
|
191.75
|
141.59
|
84.02
|
|||||
|
Interest
|
89.13
|
98.04
|
115.18
|
100.53
|
76.49
|
48.99
|
|||||
|
Other Income
|
37.46
|
50.31
|
57.32
|
49.35
|
18.49
|
21.74
|
|||||
|
Exceptional Items
|
1.33
|
1.33
|
-3.02
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
270.18
|
248.64
|
159.85
|
140.57
|
83.59
|
56.76
|
|||||
|
Provision for Tax
|
85.08
|
80.50
|
49.51
|
45.52
|
-19.64
|
13.60
|
|||||
|
Profit after Tax
|
185.10
|
168.14
|
110.34
|
95.05
|
103.23
|
43.16
|
|||||
|
Minority Interest
|
-36.73
|
-34.95
|
-26.88
|
-11.99
|
-9.13
|
-5.47
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
148.37
|
133.19
|
83.46
|
83.06
|
94.10
|
37.69
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,025.46
|
2,025.46
|
1,866.59
|
1,339.41
|
629.56
|
212.38
|
|||||
|
Minority Interest
|
-36.73
|
94.24
|
60.23
|
40.10
|
29.51
|
21.44
|
|||||
|
Non-Current Liabilities
|
1,360.57
|
1,333.68
|
1,235.02
|
936.82
|
809.33
|
572.16
|
|||||
|
Current Liabilities
|
461.48
|
461.48
|
477.76
|
399.80
|
301.32
|
206.00
|
|||||
|
Total Liabilities
|
3,941.75
|
3,941.11
|
3,664.61
|
2,751.30
|
1,822.72
|
1,024.85
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
2,340.63
|
3,341.89
|
2,851.00
|
1,957.55
|
1,459.54
|
784.50
|
|||||
|
Current Assets
|
572.97
|
572.97
|
788.60
|
758.58
|
310.18
|
227.48
|
|||||
|
Total Assets
|
3,941.75
|
3,941.11
|
3,664.61
|
2,751.30
|
1,822.72
|
1,024.85
|
|||||
|
Total Debt*
|
--
|
157.27
|
246.87
|
387.79
|
356.18
|
290.18
|
|||||
|
Net Current Assets
|
111.49
|
111.49
|
310.84
|
358.78
|
8.86
|
21.48
|
|||||
|
Contingent Liabilities
|
--
|
68.37
|
73.15
|
18.89
|
2.23
|
1.82
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
518.99
|
357.13
|
346.00
|
233.11
|
164.33
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-308.45
|
-750.33
|
-913.91
|
-509.09
|
-155.35
|
|||||
|
Cash from Financing Activities
|
--
|
-220.39
|
381.85
|
552.68
|
303.34
|
35.43
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-9.85
|
-11.35
|
-15.23
|
27.36
|
44.41
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
4.66
|
4.20
|
2.64
|
2.97
|
3.96
|
1.83
|
|||||
|
Cash EPS (₹)
|
4.68
|
14.03
|
10.80
|
9.48
|
9.74
|
6.84
|
|||||
|
Adjusted Book Value (₹)
|
65.24
|
63.55
|
58.77
|
47.63
|
26.40
|
10.32
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
16.38
|
11.31
|
370.85
|
294.10
|
239.55
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-2.02
|
-2.45
|
40.44
|
77.24
|
80.50
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
16.14
|
14.32
|
17.77
|
21.51
|
24.26
|
|||||
|
ROE (%)
|
7.47
|
8.69
|
6.92
|
9.69
|
24.58
|
21.77
|
|||||
|
ROA (%)
|
4.86
|
4.45
|
3.47
|
4.24
|
7.42
|
4.83
|
|||||
|
EBIT Margin (%)
|
14.52
|
14.18
|
12.90
|
14.39
|
13.91
|
12.07
|
|||||
|
Net Margin (%)
|
8.25
|
7.89
|
6.24
|
6.88
|
9.96
|
6.01
|
|||||
|
Cash Profit Margin (%)
|
--
|
21.36
|
19.93
|
19.92
|
22.74
|
20.23
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
22.94
|
21.57
|
28.44
|
30.86
|
46.25
|
47.73
|
|||||
|
EBIT Growth (%)
|
32.48
|
33.67
|
15.11
|
35.43
|
68.52
|
567.57
|
|||||
|
Net Profit Growth (%)
|
43.47
|
52.38
|
16.09
|
-7.92
|
139.16
|
173.94
|
|||||
|
EPS Growth (%)
|
44.40
|
59.13
|
-10.97
|
-25.01
|
116.06
|
167.94
|
|||||
|
Book Value Growth (%)
|
--
|
8.44
|
39.25
|
112.39
|
195.57
|
15.27
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
107.40
|
96.61
|
169.15
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
7.70
|
6.39
|
7.60
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
24.57
|
20.75
|
27.74
|
0.66
|
0.75
|
0.89
|
|||||
|
Close Price (₹)
|
478.95
|
406.55
|
445.85
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
568.00
|
568.00
|
464.00
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
391.15
|
327.00
|
365.70
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
15,935.32
|
12,866.75
|
14,117.63
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.07
|
0.08
|
0.13
|
0.29
|
0.57
|
1.37
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
0.01
|
0.01
|
0.05
|
|||||
|
Current Ratio
|
1.24
|
1.24
|
1.65
|
1.90
|
1.03
|
1.10
|
|||||
|
Quick Ratio
|
1.04
|
1.04
|
1.48
|
1.77
|
0.91
|
0.94
|
|||||
|
Interest Coverage
|
4.03
|
3.54
|
2.39
|
2.40
|
2.09
|
2.16
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
7.29
|
7.74
|
7.22
|
7.27
|
7.50
|
8.15
|
|||||
|
Asset Turnover
|
0.58
|
0.55
|
0.54
|
0.59
|
0.73
|
0.78
|
|||||
|
Receivable days
|
--
|
24.96
|
23.51
|
23.72
|
23.85
|
27.12
|
|||||
|
Inventory Days
|
--
|
15.29
|
14.10
|
12.05
|
12.36
|
15.94
|
|||||
|
Payable days
|
--
|
261.47
|
292.62
|
312.42
|
306.23
|
356.83
|
|||||
|
Cash Conversion Cycle
|
--
|
-221.22
|
-255.02
|
-276.65
|
-270.01
|
-313.78
|